Drugs for Schistosomiasis Market - Global Outlook and Forecast 2021-2027

January 2021 | 90 pages | ID: DC62B43CDD5DEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Drugs for Schistosomiasis in global, including the following market information:
Global Drugs for Schistosomiasis Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Drugs for Schistosomiasis Market Sales, 2016-2021, 2022-2027, (M Units)
Global top five Drugs for Schistosomiasis companies in 2020 (%)
The global Drugs for Schistosomiasis market was valued at 81 million in 2020 and is projected to reach US$ 94 million by 2027, at a CAGR of 3.6% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Schistosomiasis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drugs for Schistosomiasis Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units)
Global Drugs for Schistosomiasis Market Segment Percentages, By Type, 2020 (%)

• Praziquantel
• Oxamniquine
• Other

Global Drugs for Schistosomiasis Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units)
Global Drugs for Schistosomiasis Market Segment Percentages, By Application, 2020 (%)

• S. haematobium
• S. mansoni
• S. japonicum
• S. mekongi
• S. intercalatum

Global Drugs for Schistosomiasis Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Units)
Global Drugs for Schistosomiasis Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drugs for Schistosomiasis revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Drugs for Schistosomiasis revenues share in global market, 2020 (%)
Key companies Drugs for Schistosomiasis sales in global market, 2016-2021 (Estimated), (M Units)
Key companies Drugs for Schistosomiasis sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Shin Poong
• Merck
• Bayer
• EIPICO
• Chandra Bhagat Pharma
• Taj Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Drugs for Schistosomiasis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Drugs for Schistosomiasis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DRUGS FOR SCHISTOSOMIASIS OVERALL MARKET SIZE

2.1 Global Drugs for Schistosomiasis Market Size: 2021 VS 2027
2.2 Global Drugs for Schistosomiasis Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Drugs for Schistosomiasis Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Drugs for Schistosomiasis Players in Global Market
3.2 Top Global Drugs for Schistosomiasis Companies Ranked by Revenue
3.3 Global Drugs for Schistosomiasis Revenue by Companies
3.4 Global Drugs for Schistosomiasis Sales by Companies
3.5 Global Drugs for Schistosomiasis Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Drugs for Schistosomiasis Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Drugs for Schistosomiasis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Schistosomiasis Players in Global Market
  3.8.1 List of Global Tier 1 Drugs for Schistosomiasis Companies
  3.8.2 List of Global Tier 2 and Tier 3 Drugs for Schistosomiasis Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Drugs for Schistosomiasis Market Size Markets, 2021 & 2027
  4.1.2 Praziquantel
  4.1.3 Oxamniquine
  4.1.4 Other
4.2 By Type - Global Drugs for Schistosomiasis Revenue & Forecasts
  4.2.1 By Type - Global Drugs for Schistosomiasis Revenue, 2016-2021
  4.2.2 By Type - Global Drugs for Schistosomiasis Revenue, 2022-2027
  4.2.3 By Type - Global Drugs for Schistosomiasis Revenue Market Share, 2016-2027
4.3 By Type - Global Drugs for Schistosomiasis Sales & Forecasts
  4.3.1 By Type - Global Drugs for Schistosomiasis Sales, 2016-2021
  4.3.2 By Type - Global Drugs for Schistosomiasis Sales, 2022-2027
  4.3.3 By Type - Global Drugs for Schistosomiasis Sales Market Share, 2016-2027
4.4 By Type - Global Drugs for Schistosomiasis Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Drugs for Schistosomiasis Market Size, 2021 & 2027
  5.1.2 S. haematobium
  5.1.3 S. mansoni
  5.1.4 S. japonicum
  5.1.5 S. mekongi
  5.1.6 S. intercalatum
5.2 By Application - Global Drugs for Schistosomiasis Revenue & Forecasts
  5.2.1 By Application - Global Drugs for Schistosomiasis Revenue, 2016-2021
  5.2.2 By Application - Global Drugs for Schistosomiasis Revenue, 2022-2027
  5.2.3 By Application - Global Drugs for Schistosomiasis Revenue Market Share, 2016-2027
5.3 By Application - Global Drugs for Schistosomiasis Sales & Forecasts
  5.3.1 By Application - Global Drugs for Schistosomiasis Sales, 2016-2021
  5.3.2 By Application - Global Drugs for Schistosomiasis Sales, 2022-2027
  5.3.3 By Application - Global Drugs for Schistosomiasis Sales Market Share, 2016-2027
5.4 By Application - Global Drugs for Schistosomiasis Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Drugs for Schistosomiasis Market Size, 2021 & 2027
6.2 By Region - Global Drugs for Schistosomiasis Revenue & Forecasts
  6.2.1 By Region - Global Drugs for Schistosomiasis Revenue, 2016-2021
  6.2.2 By Region - Global Drugs for Schistosomiasis Revenue, 2022-2027
  6.2.3 By Region - Global Drugs for Schistosomiasis Revenue Market Share, 2016-2027
6.3 By Region - Global Drugs for Schistosomiasis Sales & Forecasts
  6.3.1 By Region - Global Drugs for Schistosomiasis Sales, 2016-2021
  6.3.2 By Region - Global Drugs for Schistosomiasis Sales, 2022-2027
  6.3.3 By Region - Global Drugs for Schistosomiasis Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Drugs for Schistosomiasis Revenue, 2016-2027
  6.4.2 By Country - North America Drugs for Schistosomiasis Sales, 2016-2027
  6.4.3 US Drugs for Schistosomiasis Market Size, 2016-2027
  6.4.4 Canada Drugs for Schistosomiasis Market Size, 2016-2027
  6.4.5 Mexico Drugs for Schistosomiasis Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Drugs for Schistosomiasis Revenue, 2016-2027
  6.5.2 By Country - Europe Drugs for Schistosomiasis Sales, 2016-2027
  6.5.3 Germany Drugs for Schistosomiasis Market Size, 2016-2027
  6.5.4 France Drugs for Schistosomiasis Market Size, 2016-2027
  6.5.5 U.K. Drugs for Schistosomiasis Market Size, 2016-2027
  6.5.6 Italy Drugs for Schistosomiasis Market Size, 2016-2027
  6.5.7 Russia Drugs for Schistosomiasis Market Size, 2016-2027
  6.5.8 Nordic Countries Drugs for Schistosomiasis Market Size, 2016-2027
  6.5.9 Benelux Drugs for Schistosomiasis Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Drugs for Schistosomiasis Revenue, 2016-2027
  6.6.2 By Region - Asia Drugs for Schistosomiasis Sales, 2016-2027
  6.6.3 China Drugs for Schistosomiasis Market Size, 2016-2027
  6.6.4 Japan Drugs for Schistosomiasis Market Size, 2016-2027
  6.6.5 South Korea Drugs for Schistosomiasis Market Size, 2016-2027
  6.6.6 Southeast Asia Drugs for Schistosomiasis Market Size, 2016-2027
  6.6.7 India Drugs for Schistosomiasis Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Drugs for Schistosomiasis Revenue, 2016-2027
  6.7.2 By Country - South America Drugs for Schistosomiasis Sales, 2016-2027
  6.7.3 Brazil Drugs for Schistosomiasis Market Size, 2016-2027
  6.7.4 Argentina Drugs for Schistosomiasis Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Drugs for Schistosomiasis Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Drugs for Schistosomiasis Sales, 2016-2027
  6.8.3 Turkey Drugs for Schistosomiasis Market Size, 2016-2027
  6.8.4 Israel Drugs for Schistosomiasis Market Size, 2016-2027
  6.8.5 Saudi Arabia Drugs for Schistosomiasis Market Size, 2016-2027
  6.8.6 UAE Drugs for Schistosomiasis Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Shin Poong
  7.1.1 Shin Poong Corporate Summary
  7.1.2 Shin Poong Business Overview
  7.1.3 Shin Poong Drugs for Schistosomiasis Major Product Offerings
  7.1.4 Shin Poong Drugs for Schistosomiasis Sales and Revenue in Global (2016-2021)
  7.1.5 Shin Poong Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Drugs for Schistosomiasis Major Product Offerings
  7.2.4 Merck Drugs for Schistosomiasis Sales and Revenue in Global (2016-2021)
  7.2.5 Merck Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Drugs for Schistosomiasis Major Product Offerings
  7.3.4 Bayer Drugs for Schistosomiasis Sales and Revenue in Global (2016-2021)
  7.3.5 Bayer Key News
7.4 EIPICO
  7.4.1 EIPICO Corporate Summary
  7.4.2 EIPICO Business Overview
  7.4.3 EIPICO Drugs for Schistosomiasis Major Product Offerings
  7.4.4 EIPICO Drugs for Schistosomiasis Sales and Revenue in Global (2016-2021)
  7.4.5 EIPICO Key News
7.5 Chandra Bhagat Pharma
  7.5.1 Chandra Bhagat Pharma Corporate Summary
  7.5.2 Chandra Bhagat Pharma Business Overview
  7.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Major Product Offerings
  7.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales and Revenue in Global (2016-2021)
  7.5.5 Chandra Bhagat Pharma Key News
7.6 Taj Pharmaceuticals
  7.6.1 Taj Pharmaceuticals Corporate Summary
  7.6.2 Taj Pharmaceuticals Business Overview
  7.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Major Product Offerings
  7.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Sales and Revenue in Global (2016-2021)
  7.6.5 Taj Pharmaceuticals Key News

8 GLOBAL DRUGS FOR SCHISTOSOMIASIS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Drugs for Schistosomiasis Production Capacity, 2016-2027
8.2 Drugs for Schistosomiasis Production Capacity of Key Manufacturers in Global Market
8.3 Global Drugs for Schistosomiasis Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 DRUGS FOR SCHISTOSOMIASIS SUPPLY CHAIN ANALYSIS

10.1 Drugs for Schistosomiasis Industry Value Chain
10.2 Drugs for Schistosomiasis Upstream Market
10.3 Drugs for Schistosomiasis Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Drugs for Schistosomiasis Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Drugs for Schistosomiasis in Global Market
Table 2. Top Drugs for Schistosomiasis Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Drugs for Schistosomiasis Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Drugs for Schistosomiasis Revenue Share by Companies, 2016-2021
Table 5. Global Drugs for Schistosomiasis Sales by Companies, (M Units), 2016-2021
Table 6. Global Drugs for Schistosomiasis Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Drugs for Schistosomiasis Price (2016-2021) & (USD/K Units)
Table 8. Global Manufacturers Drugs for Schistosomiasis Product Type
Table 9. List of Global Tier 1 Drugs for Schistosomiasis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Schistosomiasis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Drugs for Schistosomiasis Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Drugs for Schistosomiasis Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Drugs for Schistosomiasis Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Drugs for Schistosomiasis Sales (M Units), 2016-2021
Table 15. By Type - Global Drugs for Schistosomiasis Sales (M Units), 2022-2027
Table 16. By Application – Global Drugs for Schistosomiasis Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Drugs for Schistosomiasis Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Drugs for Schistosomiasis Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Drugs for Schistosomiasis Sales (M Units), 2016-2021
Table 20. By Application - Global Drugs for Schistosomiasis Sales (M Units), 2022-2027
Table 21. By Region – Global Drugs for Schistosomiasis Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Drugs for Schistosomiasis Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Drugs for Schistosomiasis Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Drugs for Schistosomiasis Sales (M Units), 2016-2021
Table 25. By Region - Global Drugs for Schistosomiasis Sales (M Units), 2022-2027
Table 26. By Country - North America Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Drugs for Schistosomiasis Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Drugs for Schistosomiasis Sales, (M Units), 2016-2021
Table 29. By Country - North America Drugs for Schistosomiasis Sales, (M Units), 2022-2027
Table 30. By Country - Europe Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Drugs for Schistosomiasis Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Drugs for Schistosomiasis Sales, (M Units), 2016-2021
Table 33. By Country - Europe Drugs for Schistosomiasis Sales, (M Units), 2022-2027
Table 34. By Region - Asia Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Drugs for Schistosomiasis Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Drugs for Schistosomiasis Sales, (M Units), 2016-2021
Table 37. By Region - Asia Drugs for Schistosomiasis Sales, (M Units), 2022-2027
Table 38. By Country - South America Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Drugs for Schistosomiasis Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Drugs for Schistosomiasis Sales, (M Units), 2016-2021
Table 41. By Country - South America Drugs for Schistosomiasis Sales, (M Units), 2022-2027
Table 42. By Country - Middle East & Africa Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Drugs for Schistosomiasis Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Drugs for Schistosomiasis Sales, (M Units), 2016-2021
Table 45. By Country - Middle East & Africa Drugs for Schistosomiasis Sales, (M Units), 2022-2027
Table 46. Shin Poong Corporate Summary
Table 47. Shin Poong Drugs for Schistosomiasis Product Offerings
Table 48. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2016-2021)
Table 49. Merck Corporate Summary
Table 50. Merck Drugs for Schistosomiasis Product Offerings
Table 51. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2016-2021)
Table 52. Bayer Corporate Summary
Table 53. Bayer Drugs for Schistosomiasis Product Offerings
Table 54. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2016-2021)
Table 55. EIPICO Corporate Summary
Table 56. EIPICO Drugs for Schistosomiasis Product Offerings
Table 57. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2016-2021)
Table 58. Chandra Bhagat Pharma Corporate Summary
Table 59. Chandra Bhagat Pharma Drugs for Schistosomiasis Product Offerings
Table 60. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2016-2021)
Table 61. Taj Pharmaceuticals Corporate Summary
Table 62. Taj Pharmaceuticals Drugs for Schistosomiasis Product Offerings
Table 63. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Units) (2016-2021)
Table 64. Drugs for Schistosomiasis Production Capacity (M Units) of Key Manufacturers in Global Market, 2019-2021 (M Units)
Table 65. Global Drugs for Schistosomiasis Capacity Market Share of Key Manufacturers, 2019-2021
Table 66. Global Drugs for Schistosomiasis Production by Region, 2016-2021 (M Units)
Table 67. Global Drugs for Schistosomiasis Production by Region, 2022-2027 (M Units)
Table 68. Drugs for Schistosomiasis Market Opportunities & Trends in Global Market
Table 69. Drugs for Schistosomiasis Market Drivers in Global Market
Table 70. Drugs for Schistosomiasis Market Restraints in Global Market
Table 71. Drugs for Schistosomiasis Raw Materials
Table 72. Drugs for Schistosomiasis Raw Materials Suppliers in Global Market
Table 73. Typical Drugs for Schistosomiasis Downstream
Table 74. Drugs for Schistosomiasis Downstream Clients in Global Market
Table 75. Drugs for Schistosomiasis Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Drugs for Schistosomiasis Segment by Type
Figure 2. Drugs for Schistosomiasis Segment by Application
Figure 3. Global Drugs for Schistosomiasis Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Drugs for Schistosomiasis Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Drugs for Schistosomiasis Revenue, 2016-2027 (US$, Mn)
Figure 7. Drugs for Schistosomiasis Sales in Global Market: 2016-2027 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Drugs for Schistosomiasis Revenue in 2020
Figure 9. By Type - Global Drugs for Schistosomiasis Sales Market Share, 2016-2027
Figure 10. By Type - Global Drugs for Schistosomiasis Revenue Market Share, 2016-2027
Figure 11. By Type - Global Drugs for Schistosomiasis Price (USD/K Units), 2016-2027
Figure 12. By Application - Global Drugs for Schistosomiasis Sales Market Share, 2016-2027
Figure 13. By Application - Global Drugs for Schistosomiasis Revenue Market Share, 2016-2027
Figure 14. By Application - Global Drugs for Schistosomiasis Price (USD/K Units), 2016-2027
Figure 15. By Region - Global Drugs for Schistosomiasis Sales Market Share, 2016-2027
Figure 16. By Region - Global Drugs for Schistosomiasis Revenue Market Share, 2016-2027
Figure 17. By Country - North America Drugs for Schistosomiasis Revenue Market Share, 2016-2027
Figure 18. By Country - North America Drugs for Schistosomiasis Sales Market Share, 2016-2027
Figure 19. US Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Drugs for Schistosomiasis Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Drugs for Schistosomiasis Sales Market Share, 2016-2027
Figure 24. Germany Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 25. France Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Drugs for Schistosomiasis Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Drugs for Schistosomiasis Sales Market Share, 2016-2027
Figure 33. China Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 37. India Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Drugs for Schistosomiasis Revenue Market Share, 2016-2027
Figure 39. By Country - South America Drugs for Schistosomiasis Sales Market Share, 2016-2027
Figure 40. Brazil Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Drugs for Schistosomiasis Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Drugs for Schistosomiasis Sales Market Share, 2016-2027
Figure 44. Turkey Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Drugs for Schistosomiasis Revenue, (US$, Mn), 2016-2027
Figure 48. Global Drugs for Schistosomiasis Production Capacity (M Units), 2016-2027
Figure 49. The Percentage of Production Drugs for Schistosomiasis by Region, 2020 VS 2027
Figure 50. Drugs for Schistosomiasis Industry Value Chain
Figure 51. Marketing Channels